Journals in Hematology

1-10 of 44 results in All results

Atherosclerosis

• ISSN: 0021-9150
• 5 Year impact factor: 5.3
• Impact factor: 4.9

Cardiovascular disease (CVD) causes one third of all deaths worldwide and is a major threat to global health. Atherosclerosis aims to provide a comprehensive platform for researchers, clinicians and healthcare professionals to share the latest findings and advances in the field of atherosclerosis. Atherosclerosis covers a wide range of topics, including:Pathophysiology and Mechanisms¾We explore the intricate cellular and molecular processes involved in atherogenesis, from the initial formation of fatty streaks to the development of complex plaques. We also welcome studies on cardiac biology and disease.Risk Factors¾Our examines both traditional and emerging risk factors for atherosclerosis, such as dyslipidaemia, hypertension, diabetes mellitus, thrombosis and genetic predisposition. Prevention of CVD¾ Since prevention will become a major focus in the future (see e.g. the European Cardiovascular Health Plan), an important focus will be on preventive strategies, including lifestyle modifications and pharmacological interventions.Diagnostics Techniques¾We features articles on cutting-edge diagnostic techniques, ranging from invasive procedures such as selective coronary arteriography to non-invasive techniques such as blood biomarkers.Treatment Approaches¾Atherosclerosis covers the latest developments in the treatment of atherosclerosis, including lipid-lowering therapies, anti-inflammatory treatments and novel targeted approaches aimed at modifying disease progression and improving clinical outcomes.Translational Research¾We bridges the gap between basic science and clinical practice by highlighting translational studies that bring laboratory findings closer to practical applications in patient care.By fostering collaboration and knowledge exchange between researchers and clinicians, Atherosclerosis aims to accelerate progress in the understanding, prevention and treatment of atherosclerosis, ultimately improving the lives of the millions of people affected by this pervasive disease.

Subscribe

Best Practice & Research Clinical Haematology

• ISSN: 1521-6926
• 5 Year impact factor: 2.3
• Impact factor: 2.2

Best Practice & Research Clinical Haematology provides a comprehensive review of current clinical practice and thinking within the specialty of haematology.All chapters are commissioned and written by an international team of practicing clinicians with the Guest Editors for each issue drawn from a pool of renowned experts and opinion leaders.All chapters take the form of practical, evidence-based reviews that seek to address key clinical issues of diagnosis, treatment and patient management.Each issue follows a problem-orientated approach that focuses on the key questions to be addressed, clearly defining what is known and not known. Management will be described in practical terms so that it can be applied to the individual patient.Boxed and bulleted Learning Objectives and Practice Points are features within each chapter and will highlight the core and essential knowledge that will help the physician to provide the best care to their patients.

Subscribe

Biochimica et Biophysica Acta: Proteins and Proteomics

• ISSN: 1570-9639
• 5 Year impact factor: 2.8
• Impact factor: 2.5

BBA Proteins and Proteomics covers protein structure conformation and dynamics; protein folding; protein-ligand interactions; enzyme mechanisms, models and kinetics; protein physical properties and spectroscopy; and proteomics and bioinformatics analyses of protein structure, protein function, or protein regulation.The journal no longer considers manuscripts dealing with binding of compounds such as drugs or drug analogues to circulatory proteins such as serum albumin. These studies are better accommodated in journals dealing with drug design and development.Manuscripts must advance our insights into the molecular and mechanistic properties of proteins. Computational studies must generally be validated or complemented by experimental studies. Studies only consisting of computational work will not be considered unless they provide new theoretical insight that allows us to better understand or reinterpret surprising or unexpected experimental data.Comparative proteomics studies are generally not considered for review unless they provide specific insights into the structural and/or functional properties of individual proteins. Proteomics studies must also address properties of individual proteins and should as far as possible be validated by direct investigations of relevant identified proteins.Concise and comprehensive reviews of recent developments are considered for publication. However, authors are strongly advised to consult one of the Executive Editors before starting a review.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscribe

Blood

• ISSN: 0006-4971
• 5 Year impact factor: 19.2
• Impact factor: 21

Blood, the flagship journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Acceptance of manuscripts is based on the originality and importance of the observations or investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well-organized and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication.Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate. Authors are invited to submit a presubmission inquiry if they are uncertain whether their work falls within the general scope of the journal.Blood has formulated more precise scopes for immunobiology and immunotherapy, vascular biology, HIV/HTLV, and clinical trial submissions. The journal is very interested in submissions as reflected in the definitions linked below.Immunobiology and Immunotherapy scopeVascular Biology scopeHIV/HTLV scopeClinical Trials scopeBlood welcomes submission of manuscripts reporting on clinical trials whether phase 1, 2, 3 or 4. Reports should include a full description of the study design, patient population, methodology and conduct, and statistical plan.Immunobiology and Immunotherapy encompass a wide spectrum of research, but Blood can accommodate only papers that have clear and important implications for hematology. Preference is given to papers focusing on human immunobiology, immunotherapy, and immune pharmacology approaches in the human setting and those with significant implications for understanding of normal or malignant hematologic processes. Papers on tumor immunology, tumor vaccines and cancer immunotherapy development may be appropriate if the target cells or antigens are relevant to hematologic malignancies, but generally Blood cannot accommodate tumor immunology papers focusing solely on non-hematologic tumor types.Papers investigating autoimmunity and utilizing non-hematologic models are not within the scope of Blood.Vascular biology papers that focus primarily on atherosclerosis are outside the scope of Blood and instead should be considered for alternative journals.Papers felt to be outside the scope of Blood will be returned to the author without full peer review.

Subscribe

Blood Cells, Molecules and Diseases

• ISSN: 1079-9796
• 5 Year impact factor: 2.2
• Impact factor: 2.1

BCMD is interested in contributions in basic, translational and clinical research focusing on the biology of blood cells and the pathophysiology of blood disorders, with a specific interest in non-malignant conditions.We will consider studies on hematological malignancies when secondary to inherited or acquired bone marrow failure or disorders of the immune system.Research Areas include:Erythropoiesis, Erythrocyte Biology, Hemoglobin and its disordersMyelopoiesis, myeloid cells and disorders of the myeloid lineage (incl. myeloproliferative disorders)Megakaryopoiesis and platelet disordersHemostasis & Thrombosis and disorders of coagulationTransfusion medicine and the study of therapeutic blood products (including novel biotechnologies related to transfusion products)Bone marrow failure (severe aplastic anemia, myelodysplasia, etc.)Immunodeficiency and dysregulation of the immune systemAuto-immune disorders relating to blood

Subscribe

Blood Immunology & Cellular Therapy

• ISSN: 3050-5976

Blood Immunology & Cellular Therapy provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations related to blood immunology. The journal welcomes original work relevant to hematological disease with significant clinical or scientific impact, including papers relevant to immunotherapy, transplantation biology, transplantation, and immunodiagnostics. Immune responses against diseases or viruses would generally be outside the scope but approaches to treat viral infections in the post-transplant setting, e.g., CMV-specific responses, might be of interest.

Subscribe

Blood Red Cells & Iron

• ISSN: 3050-5984

Blood Red Cells and Iron provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations related to red blood cells. The journal welcomes original work relevant to hematological disease involving erythroid lineage with significant clinical and/or scientific impact. The submissions can include papers relevant to inherited and acquired anemias, nutritional anemias, sickle cell disease, thalassemia, malaria, immune-mediated anemias, and normal and ineffective erythropoiesis including myelodysplasia.

Subscribe

Blood Reviews

• ISSN: 0268-960X
• 5 Year impact factor: 7.7
• Impact factor: 6.9

This respected international journal, Blood Reviews, is a vital information resource, bringing together appraisals of clinical practice, and research from recognized experts. Specially commissioned peer reviewed articles from leading researchers and practitioners guarantee truly global coverage of all the sub-specialties of hematology.Blood Reviews publishes review articles covering the spectrum of clinical and laboratory haematological practice and research. Although most reviews are invited, the Editors welcome suggestions from potential authors. They should first write a brief outline of an intended review along with their publication record on topic and send this to Dr Drew Provan ([email protected]) or to Dr Hillard Lazarus ([email protected]). All articles are subject to peer review. Author queries can also be sent to the Blood Reviews editorial office [email protected]

Subscribe

Cancer Epidemiology

• ISSN: 0361-090X
• 5 Year impact factor: 2.7
• Impact factor: 2.4

Cancer determinants, prevention, prognosis and outcomesCancer Epidemiology publishes original research, prioritizing studies that contribute new information about cancer causes, prevention and control. As such, the journal's scope covers all aspects of cancer epidemiology including studies of:• Risk factors for cancer initiation, development, and prognosis • Early detection, prevention, and screening • Survivorship • Descriptive patterns and trends • MethodologyCancer Epidemiology welcomes original articles, reviews (systematic and critical), meta-analyses, invited editorials and commentaries, as well as letters to the editor commenting on research previously published in the journal.Cancer Epidemiology (Cancer Epidemiol.) is indexed and abstracted in: MEDLINE/PubMed, Current Contents/Clinical Medicine, the Science Citation Index Expanded, and Thomson Reuters Journal Citation Reports (Science Edition).

Subscribe

Cancer Epidemiology

• ISSN: 1877-7821
• 5 Year impact factor: 2.7
• Impact factor: 2.4

Cancer determinants, prevention, prognosis and outcomesCancer Epidemiology publishes original research, prioritizing studies that contribute new information about cancer causes, prevention and control. As such, the journal's scope covers all aspects of cancer epidemiology including studies of:• Risk factors for cancer initiation, development, and prognosis • Early detection, prevention, and screening • Survivorship • Descriptive patterns and trends • MethodologyCancer Epidemiology welcomes original articles, reviews (systematic and critical), meta-analyses, invited editorials and commentaries, as well as letters to the editor commenting on research previously published in the journal.Cancer Epidemiology (Cancer Epidemiol.) is indexed and abstracted in: MEDLINE/PubMed, Current Contents/Clinical Medicine, the Science Citation Index Expanded, and Thomson Reuters Journal Citation Reports (Science Edition).

Subscribe